• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Myriad Genetics

Anonymous board for Myriad Genetics
Replies
0
Views
918
anonymous
Replies
1
Views
8K
anonymous